๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

12 recruiting trials

for HDV

Rapid T-cell Analysis Test in Patients With Chronic HBV and HBV/HDV Disease NCT06372990n/a1 site๐Ÿ“ Milan Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide NCT07429864n/a1 site๐Ÿ“ Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS Non-interventional Study to Assess the Number of People With Untreated/Unknown HBV + HDV and HCV in South-East Austria NCT06834178n/a1 site๐Ÿ“ Graz Vanessa Stadlbauer-Koellner, MD A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2) NCT07200908Phase 357 sites๐Ÿ“ Graz๐Ÿ“ Sankt Pรถlten๐Ÿ“ Brno Mirum Pharmaceuticals, Inc. ยท Tests: Brelovitug 300 mg, Bulevirtide 2 mg and Brelovitug - 300 mg HDV Screening Study NCT06889805n/a1 site๐Ÿ“ Hong Kong Grace Lai Hung Wong Immunological and Virological Characterization of Patients With Chronic HBV-HDV Infection: Outcomes and Response to Bulevirtide Treatment NCT06504485n/a1 site๐Ÿ“ Milan Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico ยท Tests: Bulevirtide ePro Diary - HDV ( MACROLIVER ) NCT07442760n/a1 site๐Ÿ“ Bergamo FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS Hepatitis Delta Virus Infection: Cross-sectional Study in Patients With Chronic Hepatitis B Virus Infection NCT06638320n/a3 sites๐Ÿ“ Hร  Nแป™i๐Ÿ“ Hร  Nแป™i๐Ÿ“ Ho Chi Minh City Tam Anh Research Institute National Cohort of Patients Co-infected With Hepatitis B and Delta Viruses NCT04166266n/a38 sites๐Ÿ“ Angers๐Ÿ“ Annecy๐Ÿ“ Bobigny ANRS, Emerging Infectious Diseases ยท Tests: Blood draw for the laboratory assessment A Phase III Study to Evaluate the Efficacy and Safety of Libevitug in Participants With Chronic HDV Infection (D-clear Study) NCT07499544Phase 37 sites๐Ÿ“ Garden Grove๐Ÿ“ Changchun๐Ÿ“ Kashgar Huahui Health ยท Tests: Libevitug 20 mg/kg, Libevitug 10 mg/kg, Delayed treatment with libevitug Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus NCT07096193Phase 1, Phase 228 sites๐Ÿ“ Anaheim๐Ÿ“ La Jolla๐Ÿ“ Louisville Gilead Sciences ยท Tests: GS-4321, GS-4321 Placebo, GS-4321 D-SOLVE Cohorts (Cohort A and B) NCT06160635n/a4 sites๐Ÿ“ Hanover๐Ÿ“ Milan๐Ÿ“ Bucharest Hannover Medical School
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy